Home » Topics » Regulatory

Regulatory
RSS

Topical t-PA for the treatment of venous ulcers

July 2, 1997

TIMI-IIA finds enoxaparin promising

July 1, 1997

Epilepsy monotherapy approved in Canada

July 1, 1997

New indication for enoxaparin recommended for approval

June 27, 1997

Advisory committee recommends Taxol for KS

June 27, 1997

RTP Pharma receives U.S. patent for new formulation of propofol

June 25, 1997

Minocycline superior to placebo for early RA

June 25, 1997

Pulmicort Turbuhaler approved by FDA

June 25, 1997

Combination therapy approved by FDA for H. pylori eradication

June 20, 1997

Coreg now available in the U.S. for heart failure

June 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...